Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single ascending intravenous dose study of E3112 in Japanese healthy adult males
jRCT2080223364Phase 1
- Sponsor
- EA Pharma Co., Ltd.
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing E3112 with Placebo (2 arms).
02
Drugs
olamepermin alfa
Beyond the preview
Go deeper on jRCT2080223364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223364.